[go: nahoru, domu]

US20090188811A1 - Preparation and maintenance of sensors - Google Patents

Preparation and maintenance of sensors Download PDF

Info

Publication number
US20090188811A1
US20090188811A1 US12/276,230 US27623008A US2009188811A1 US 20090188811 A1 US20090188811 A1 US 20090188811A1 US 27623008 A US27623008 A US 27623008A US 2009188811 A1 US2009188811 A1 US 2009188811A1
Authority
US
United States
Prior art keywords
sensor
circuit
packaging
rupturable
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/276,230
Inventor
Michael Higgins
Mark Konno
Todd Fjield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Priority to US12/276,230 priority Critical patent/US20090188811A1/en
Priority to CN201310375802.6A priority patent/CN103529094A/en
Priority to AT08857379T priority patent/ATE545861T1/en
Priority to KR1020107014075A priority patent/KR20100103534A/en
Priority to EP11194971.5A priority patent/EP2434277B1/en
Priority to CA2706592A priority patent/CA2706592A1/en
Priority to EP08857379A priority patent/EP2223094B1/en
Priority to PCT/US2008/084568 priority patent/WO2009073450A1/en
Priority to CN200880125648.4A priority patent/CN101925811B/en
Assigned to EDWARDS LIFESCIENCES CORPORATION reassignment EDWARDS LIFESCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HIGGINS, MICHAEL J., KONNO, MARK, FJIELD, TODD
Publication of US20090188811A1 publication Critical patent/US20090188811A1/en
Priority to US13/430,492 priority patent/US8834703B2/en
Priority to US14/459,643 priority patent/US20140353153A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/4875Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/24Hygienic packaging for medical sensors; Maintaining apparatus for sensor hygiene
    • A61B2562/242Packaging, i.e. for packaging the sensor or apparatus before use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495Calibrating or testing of in-vivo probes

Definitions

  • the time it takes a sensor to be conditioned and become capable of making measurements is often referred to as its run-in period. Run-in periods can last for as little as a few minutes to as long as a few days.
  • the type of conditioning and run-in time required for each type or kind of sensor will vary depending on the condition of the sensor and the intended purpose and design of the sensor being used.
  • electrochemical sensors often contain electrodes at which electrochemical reactions take place, an electrolytic solution or transport matrix in which the reactions take place, and a membrane to control the access of analyte species.
  • Examples of the types of conditions that control the length of run-in time include the time it takes for the appropriate oxidation or reduction of chemical species at the electrodes before the desired reactions to take place, the consistency of the electrolytic solution or transport matrix, and the hydration of the membrane. Regardless of the type of conditioning required for a particular sensor, a sensor sealed within a container without access to required compounds or signals cannot undergo run-in conditioning.
  • the apparatus and methods for preparing sensors are utilized in advance of the sensor being removed from a sealed sterilized package.
  • the apparatus for preparing sensors include packaging materials incorporating electrical circuits capable of exciting or stabilizing a sensor.
  • the methods for preparing sensors include methods of providing a solution to a sterilized packaging containing a sensor connected to a sensor activating circuit without compromising the sterilizable packaging, activating a circuit electrically connected to the sensor, and allowing the sensor to stabilize. The providing and activating steps preferably occur without breaching the sterilized packaging.
  • apparatus for stabilizing a sensor that is in use.
  • These apparatus include a circuit connectable to the sensor that provides a signal to the sensor that prevents the sensor from becoming destabilized when disconnected from a monitoring device.
  • a circuit can prevent a sensor from becoming depolarized by, for example, providing an appropriate electrical current or potential.
  • These apparatus can also include a rechargeable voltage source and/or a recordable storage medium that is capable of recording data related to a sensor.
  • FIG. 1 is an illustration of an electrochemical sensor.
  • FIG. 1A is a schematic of a circuit.
  • FIG. 2 is a cross-sectional view of the working electrode of the electrochemical sensor of FIG. 1 .
  • FIG. 3 is a perspective view of a sterilizable packaging in the form of a sealable pouch.
  • FIG. 4 is a rupturable solution container in the shape of a cylinder.
  • FIG. 5 is a cut away view of a sealable pouch with an alternative embodiment of a rupturable solution container that is partially formed using the back portion of the sealable pouch.
  • FIG. 6 is a cut away view of a sealable pouch containing a sensor connected to a circuit capable of exciting the sensor.
  • FIG. 7 is a cut away view of a sealable pouch containing a sensor connected to a circuit capable of exciting the sensor and a rupturable solution container.
  • FIG. 8 is a block diagram showing a configuration of a sensor connected in series to a circuit then to a monitoring device.
  • FIG. 9 is a block diagram showing an alternative configuration of the circuit connected to the sensor and monitoring device connected to the sensor not in series.
  • FIG. 10 is a block diagram showing an alternative configuration with the circuit and the sensor integrated into a single unit and connected to a patient monitoring cable and a monitoring device in series.
  • FIG. 11 is a block diagram showing an alternative configuration with the circuit integrated into a patient monitoring cable such that the circuit is not removed when the sensor is in use.
  • FIG. 12 is a block diagram showing an alternative configuration with the circuit removeably connectable to a patient monitoring cable.
  • FIG. 13 is a block diagram showing an alternative configuration with the circuit housed in a module to which the sensor and monitoring device can be connected.
  • the apparatus and methods for preparing sensors for use are utilized in advance of the sensor being removed from a sealed sterilized package.
  • the apparatus include packaging materials having electrical circuits capable of stabilizing a sensor to prepare the sensor for use.
  • the methods for preparing a sensor for use include methods of providing a solution to a sterilized packaging that contains a sensor and activating a circuit electrically connected to the sensor. These methods can be performed without compromising the sterilized packaging and allow time for the sensor to stabilize.
  • apparatus for stabilizing a sensor that is in use.
  • These apparatus include a circuit connectable to the sensor that provides a signal to the sensor that prevents the sensor from becoming destabilized when disconnected from a monitoring device.
  • a circuit for stabilizing a sensor during use can be similar to or the same as a circuit for preparing a sensor for use.
  • a sensor 10 for measuring an analyte includes a reference electrode 20 , an optional counter electrode 30 , and a working electrode 40 provided on a substrate 50 .
  • the electrodes ( 20 , 30 , 40 ) are formed of a conductive material.
  • the reference electrode 20 can be, for example, an Ag/AgCl electrode.
  • the counter electrode 30 and working electrode 40 can be, for example, graphite and platinum.
  • the reference electrode 20 establishes a fixed potential from which the potential of the counter electrode 30 and working electrode 40 can be established.
  • the counter electrode 30 provides a working area for conducting the majority of electrons from, for example, an oxidation reaction back to the solution being analyzed, i.e., blood.
  • Electrode 20 is connected to the reference electrode 20 and working electrode 40 for applying and/or measuring current or potential at or between the electrodes.
  • electrochemical sensors can include multiple reference electrodes, counter electrodes, and working electrodes as would be understood by one of skill in the art.
  • the electrically conductive wires 60 can be connected to a circuit.
  • An example of a circuit 62 is shown in FIG. 1A .
  • a circuit 62 can include a parallel resistor 64 to limit voltage drop, a switch 66 , and a voltage source 68 such as a battery, as shown in FIG. 1A .
  • Such a circuit 62 can be a current controlled voltage source that provides a constant voltage.
  • An example of a range of voltages for use in such a circuit 62 is about 0.2 V to about 2 V, other ranges of voltages include about 0.4 V to about 1.5 V, about 0.5 V to about 1 V, and about 0.6 V to about 0.7 V.
  • Other circuit designs that provide a current controlled voltage source that provides a constant voltage will be apparent to one of skill in the art.
  • other electrical components can be used instead of or with the parallel resistor 64 such as a capacitor to help control the voltage of the circuit.
  • FIG. 2 shows a cross-section of the area enclosed by the dashed area 55 in FIG. 1 .
  • the working electrode 40 is covered by an analyte selective membrane 70 which also covers a reagent layer 80 .
  • Reagent layer 80 is selected to react with one or more specific analytes found or expected to be found in a fluid to be analyzed.
  • the reagent layer 80 can contain glucose oxidase, such as may be derived from Aspergillus niger (EC 1.1.3.4), type II or type VII.
  • Reagent layer 80 can also include a matrix such as a hydrogel to promote a reaction between the reagent and an analyte that passes through the membrane 70 .
  • a hydrogel for example, can be water absorbent and swell to provide active transport of an analyte in a fluid under analysis (e.g., glucose) from the fluid into the reagent layer 80 .
  • FIG. 3 is a perspective view of a sterilizable packaging in the form of a sealable pouch 100 .
  • FIG. 3 illustrates a sealable pouch 100
  • any other form of sterilizable packaging can be used in accordance with the invention.
  • the sealable pouch 100 is made of a material such as a polymer that can maintain a sterilized environment and is typically liquid and vapor impermeable.
  • the sealable pouch 100 is referred to as being sealable rather than sealed because, as depicted, one end 110 is open.
  • the sealable pouch 100 can be sealed using an adhesive composition or heat sealing (melting) in the case of a polymer.
  • the sealable pouch 100 can be made from flexible materials or a mixture of flexible, rigid, or substantially rigid materials.
  • the sealable pouch could include a rigid back portion, i.e., a rigid backing, and a flexible front portion.
  • a resealable portion 112 can be used to provide solution to the sealable pouch 100 .
  • the resealable portion 112 can for example be a self-sealing membrane 114 through which a syringe can be inserted.
  • a partial view of a rupturable solution container 120 that is inserted into the sealable pouch 100 .
  • the rupturable solution container 120 is also shown in FIG. 4 .
  • the rupturable solution container 120 is cylindrical, though other shapes and configurations are possible. Additionally, the size of the rupturable solution container 120 can be varied to accommodate the volume of solution desired to be delivered to the sealable pouch 100 .
  • the rupturable solution container 120 is made from a material, such as a polymer, that is more easily ruptured than the material used to make the sealable pouch 100 .
  • a more easily ruptured material is used so the rupturable solution container 120 can be ruptured while on the interior of the sealable pouch 100 using forces that will not breach the sealable pouch 100 .
  • the sealable pouch 100 will not be breached at any point along the material used to form the sealable pouch 100 or any point where two or more portions of the sealable pouch 100 are sealed together, e.g., along a seam, when the rupturable container is ruptured.
  • the ability to maintain the integrity of the sealable pouch 100 allows the maintenance of a sterilized state for any contents of the sealable pouch 100 .
  • the rupturable solution container 120 can be attached to an inner portion of the sealable pouch 100 through the use, for example, of an adhesive or by forming the rupturable solution container as part of the sealable pouch. Attaching the rupturable solution container 120 to an inner portion of the sealable pouch 100 can provide consistency in the positioning of the rupturable solution container 120 for ease of use.
  • the terms rupture and breach and their derivatives are used herein to indicate that a container has been opened such that the contents of a container are able to move from the interior of the container to the exterior of the container.
  • the solution can be provided in the rupturable solution container 120 when the sealable pouch 100 is sealed and shipped and/or stored, or the sealable pouch can be sealed and the rupturable solution container filled through the use of a resealable portion 112 and a syringe as discussed above.
  • FIG. 5 An alternative design for the rupturable solution container 130 is shown in FIG. 5 .
  • a rupturable solution container 130 is shown in which a portion of the rupturable solution container 130 is formed by an interior surface 140 of the sealable pouch 100 .
  • a rupturable solution container 130 the more easily ruptured material is used to form the interior side 170 of the rupturable solution container 130 , which ruptures prior to a breach of the material used to form the sealable pouch 100 to allow the solution into the sealable pouch 100 .
  • the types of polymers or other materials for use in such containers can include, for example, polypropylene or polyethylene film or sheet.
  • the tear strength i.e., the resistance of a material to tear forces (as might be measured by ASTM D 1922), is a relevant property for the apparatus and methods described herein.
  • the relative tear strengths of the materials used for the rupturable solution container 120 and the sealable pouch 100 are important in determining the material for use as the rupturable solution container 120 in that the tear strength of the material for use as the rupturable solution container 120 will be less than the tear strength of the sealable pouch 100 .
  • the sealable pouch 100 described herein can be used to contain a sensor such as an electrochemical sensor.
  • An example of an electrochemical sensor is a blood glucose sensor.
  • the run-in period for a sensor located in a sealable pouch 100 as described herein that has a sensor sealed inside can be begun by providing an electrolytic, i.e., conductive, solution to the sealable pouch 100 .
  • the electrolytic solution can be medically safe and non-toxic, e.g., sterile saline.
  • the electrolytic solution can be provided from an external source or contained, for example, in a rupturable solution container 120 , which can provide solution to the sealable pouch 100 when ruptured.
  • run-in time is the time it takes for the sensor to reach equilibrium and to be ready for measurement.
  • Electrolytic solution can be provided, for example, by introducing a solution through a resealable portion of the sealable pouch, such as, for example, by injection through the resealable membrane 114 .
  • Run-in time can be considered to include multiple phases such as hydration (i.e., the time for the sensor to come into contact and equilibrate with a solution) and polarization (i.e., the time for the sensor to stabilize once voltage is applied to the sensor). These phases can occur simultaneously or overlap. If aspects of the sensor other than hydration remain to be activated or run-in after exposure to the solution, such as aspects of the sensor that are dependent on the presence of an electric potential, these aspects for preparing the electrode can then be performed after the solution is added. If the circuit is connected to the sensor prior to the addition of solution, both hydration and electrical stabilization can begin as soon as the system comes into contact with the electrolytic solution. Electrical stabilization of the sensor can include non-Faradaic responses.
  • a sensor can be connected to a circuit designed to excite the sensor, such as, for example, the circuit shown in FIG. 1A .
  • a sensor 200 can be electrically connected to a circuit capable of exciting the sensor 300 with both the sensor 200 and circuit capable of electrically exciting the sensor 300 located within the sealable pouch 100 .
  • the circuit 300 can be provided in the sterilized sealable pouch 100 and can be activated within the sealable pouch 100 without exposing the sensor 200 to the outside environment.
  • the circuit capable of electrically exciting the sensor 300 can be manually activated through the use of a force external to the sealable pouch 100 such as by the activation of a switch, remotely activated through the use of an external signal, or automatically activated upon the provision of a solution to the sealable pouch 100 .
  • an electrical connection for activating the circuit 300 can be provided on a surface of the sealable pouch 100 and manually activated without opening the pouch or a complete circuit can be integrated into the sealable pouch 100 that is activated upon the provision of an electrolytic solution.
  • the phrase “excite the sensor” refers to providing an electrical signal to the sensor 200 such that the sensor achieves, remains at or close to, or approaches a condition at which it can take sensor readings with little or no additional electrical preparation.
  • Such an electrical signal can include, for example, a current controlled constant or periodic potential provided by, for example, a current controlled voltage source that provides a constant voltage, which is applied to a reference electrode 12 and/or a working electrode 16 such as those shown in FIG. 3 .
  • the number and type of electrical signals can depend on the number and state the electrodes will need to be in when the sensor 300 is used for sensing.
  • FIG. 7 shows an embodiment in which a circuit capable of electrically exciting the sensor 300 and alternatively a resealable portion 112 and/or a rupturable solution container 120 are included in a sealable pouch 100 .
  • the circuit capable of electrically exciting the sensor 300 can be activated at or around the time the rupturable solution container 120 is ruptured through, for example, the use of a fluid sensor located within the pouch.
  • Methods for preparing a sensor for use include providing a solution such as an electrolytic solution to a sterilized packaging containing a sensor without compromising the sterilizable packaging then allowing the sensor to stabilize in the solution.
  • the sensor can be connected to a sensor activating circuit before or after the provision of the electrolytic solution. If the sensor is connected to a sensor activating circuit after solution is provided, the sensor activating circuit can be activated and the electrical aspects of the system can be run-in.
  • the circuit can be activated by an external force, such as moving a switch, or automatically when the solution is provided.
  • solution can be provided and a switch activated to initiate the sensor activating circuit.
  • solution can be provided and the sensor activating circuit can be activated by the presence of solution.
  • Such sensors are described above and can include a glucose sensor.
  • solutions for use with the apparatus and methods herein include, but are not limited to, buffer solutions, saline solutions, solutions containing electrolytes or other chemicals needed either for chemical reactions at the electrodes or for other electrode preparations, and mixtures thereof.
  • the several sensor run-in preparations described herein may or may not completely prepare a sensor for use. However, the sensor will be closer to an operational state than if the run-in preparations did not occur.
  • a glucose sensor for example, is in use
  • hydrogen peroxide is produced in the presence of glucose at the electrode
  • the hydrogen peroxide is converted to electrons
  • the electrons are measured at the working electrode.
  • a glucose sensor is first exposed to glucose there is a lag time before electrons are produced at a steady-state indicating the glucose level. After a steady-state is obtained, if voltage is discontinued to the electrodes, the sensor depolarizes, i.e., electrons are no longer attracted to the working electrode, but the reaction to form hydrogen peroxide still occurs.
  • the excess hydrogen peroxide needs to be converted and the measurement from the sensor will appear higher than the actual glucose level.
  • the sensor takes some time to equilibrate and provide a steady-state reading indicative of the glucose level.
  • apparatus for stabilizing a sensor that is being prepared for use, e.g., during initial implantation, or already in use.
  • These apparatus include a circuit connectable to a sensor for providing a signal, such as an electrical current or potential, to the sensor.
  • a signal can include, for example, a constant or periodic potential applied to a reference electrode 12 and/or a working electrode 16 such as those shown in FIG. 3 .
  • the signal chosen to be sent to the sensor is one that prevents the sensor from becoming destabilized prior to being connected or upon being disconnected from a monitoring device.
  • the circuit can prevent the sensor from becoming depolarized. When the electrodes of a sensor become depolarized the sensor cannot be used immediately and another run-in period becomes necessary to repolarize the electrodes.
  • a glucose sensor for example, has a chemical component to maintain a stabilized state, i.e., if a glucose sensor is in the presence of glucose, hydrogen peroxide conversion takes place and excess hydrogen peroxide will need to be converted prior to obtaining accurate glucose level readings. However, if the glucose sensor retains its electrical potential excess hydrogen peroxide does not accumulate at the working electrode.
  • a sensor 400 can be connected to a circuit 500 and a monitoring device 600 .
  • FIG. 9 shows an alternative configuration in which the circuit 500 and monitoring device 600 are not connected to the sensor 400 in series, i.e., there are two possible connections to the sensor 400 .
  • a signal is continually provided to excite the sensor 400 . Maintaining a signal to excite the sensor 400 is accomplished by maintaining a connection with a power source, such as a power source from either the circuit 500 or monitoring device 600 .
  • a signal to excite the sensor 400 is provided by another source, such as a battery of a charged capacitor communicating with the sensor 400 .
  • the sensor 400 can be an electrochemical sensor such as a glucose sensor.
  • the circuit 500 can be configured to connect to a sensor 400 continuously such that the circuit 500 is connected to the sensor 400 both when the sensor 400 is connected to and when the sensor 400 is disconnected from a monitoring device 600 .
  • a circuit 500 can be configured to be capable of being removed from the sensor 400 when the sensor 400 is connected to a monitoring device 600 or an alternate signal source and reconnected to the sensor 400 when the sensor 400 is to be disconnected from the monitoring device 600 , with the provision that a signal to excite the sensor 400 is continually applied to the sensor 400 .
  • the sensor 400 and circuit 500 are integrated into a single unit.
  • the sensor 400 and circuit 500 are integrated into a single unit that is disposable.
  • the circuit 500 can either be integrated into the cable 510 so it is not removed when the sensor 400 is in use as shown in FIG. 11 , or the circuit 500 can be removeably connectable to the patient monitoring cable 510 as shown in FIG. 12 . If the circuit 500 is removeably connectable to a patient monitoring cable 510 , the monitoring device 600 to which the patient monitoring cable 510 is connected is capable of providing a signal to the sensor 400 . Then, when the patient monitoring cable 510 is to be disconnected from the monitoring device 600 , the circuit 500 provides a signal to the sensor 400 in the absence of the signal from the monitoring device 600 .
  • the circuit 500 When the circuit 500 is integrated into a device, such as a patient monitoring cable 510 , and the circuit 500 is not disconnected from the sensor 400 when the sensor 400 is connected to a monitoring device 600 , the circuit 500 can be configured such that there is a manual mechanism for disconnecting the circuit 500 from the sensor 400 or the circuit 500 can be configured to automatically disconnect in the presence of another signal source, e.g., a voltage source. Alternatively, when the sensor 400 is connected to the monitoring device 600 , the circuit 500 can continue to provide a signal to the sensor 400 with the monitoring device 600 providing power for the circuit 500 to operate or charging the power source of the circuit 500 .
  • a device such as a patient monitoring cable 510
  • the circuit 500 can be configured such that there is a manual mechanism for disconnecting the circuit 500 from the sensor 400 or the circuit 500 can be configured to automatically disconnect in the presence of another signal source, e.g., a voltage source.
  • the circuit 500 can continue to provide a signal to the sensor 400 with the monitoring device 600 providing power for the circuit 500 to
  • circuits 500 such as those described can be housed in modules 520 to which a sensor 400 can be connected and which can be in turn connected in series to a monitoring device 600 .
  • a monitoring device 600 can be configured to accept a module 520 containing a circuit 500 .
  • a circuit 500 can include a rechargeable voltage source, e.g., a rechargeable battery.
  • the circuit 500 can be configured to recharge the rechargeable power source when the circuit is connected to a monitoring device.
  • the rechargeable power source can be charged or recharged at a charging station which can be used to initially charge a rechargeable voltage source connected to a circuit 500 or maintain a charge if a sensor 400 remains disconnected from a monitoring device 600 for an extended period of time.
  • a recharging station can have multiple positions for simultaneously charging multiple circuits 500 .
  • a recordable storage medium (not shown) can be included in the circuit 500 .
  • the recordable storage medium such as an electrically erasable programmable read-only memory (EEPROM), can, for example, record data corresponding to the sensor 400 .
  • Data corresponding to the sensor 400 can include time data, such as total time in service or time since last connected to a monitoring device 600 , calibration data, or sensor reading or condition data. Such data can, for example, be recorded from sensor readings, internal timing devices, or other sensor 400 or circuit 500 generated data, or transferred to the circuit 500 prior to the sensor 400 being disconnected from a monitoring device 600 .
  • the circuit 500 can include the ability to wirelessly transmit data to a monitoring device when a sensor 400 is detached from the monitoring device and the ability to log readings upon disconnect (either accidental or intentional) for transmittal to a monitoring device when reattached.
  • Circuits 500 such as those described can be housed in modules to which a sensor 400 can be connected and which can be in turn connected in series to a monitoring device 600 . Such a circuit 500 can also be integrated into a device containing a sensor 400 .
  • a monitoring device 600 can be configured to accept a module containing a circuit 500 .
  • sensors 400 can, for example, be incorporated into devices including medical devices such as patient monitoring cables.
  • Circuits 500 can be, for example, incorporated into devices incorporating sensors or devices designed to connect to sensors. Where a storage capacitor is used as a signal source as described above, it can also be incorporated into devices in the same manner as the circuit 500 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

Apparatus and methods are described for preparing, maintaining, and stabilizing sensors. The apparatus and methods for preparing sensors for use are utilized in advance of the sensor being removed from a sealed, sterilized package. The apparatus include packaging materials having electrical circuits capable of stabilizing a sensor to prepare the sensor for use. The methods for preparing a sensor for use includes methods of providing a solution to a sterilized packaging that contains a sensor connected to a sensor activating circuit, activating the circuit, and allowing the sensor to stabilize. These methods can be performed without compromising the packaging. The apparatus for stabilizing a sensor that is in use include a circuit connectable to the sensor that provides a signal to the sensor that prevents the sensor from becoming destabilized when disconnected from a monitoring device.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application claims priority from U.S. provisional patent application No. 60/990,797, filed on Nov. 28, 2007, which is also hereby incorporated herein by reference.
  • BACKGROUND
  • Before some sensors are capable of making their intended measurements, they go through some form of conditioning. The time it takes a sensor to be conditioned and become capable of making measurements is often referred to as its run-in period. Run-in periods can last for as little as a few minutes to as long as a few days. The type of conditioning and run-in time required for each type or kind of sensor will vary depending on the condition of the sensor and the intended purpose and design of the sensor being used. For example, electrochemical sensors often contain electrodes at which electrochemical reactions take place, an electrolytic solution or transport matrix in which the reactions take place, and a membrane to control the access of analyte species. Examples of the types of conditions that control the length of run-in time include the time it takes for the appropriate oxidation or reduction of chemical species at the electrodes before the desired reactions to take place, the consistency of the electrolytic solution or transport matrix, and the hydration of the membrane. Regardless of the type of conditioning required for a particular sensor, a sensor sealed within a container without access to required compounds or signals cannot undergo run-in conditioning.
  • SUMMARY
  • Apparatus and methods for preparing and maintaining sensors, such as electrochemical sensors, are disclosed. The apparatus and methods for preparing sensors are utilized in advance of the sensor being removed from a sealed sterilized package. The apparatus for preparing sensors include packaging materials incorporating electrical circuits capable of exciting or stabilizing a sensor. The methods for preparing sensors include methods of providing a solution to a sterilized packaging containing a sensor connected to a sensor activating circuit without compromising the sterilizable packaging, activating a circuit electrically connected to the sensor, and allowing the sensor to stabilize. The providing and activating steps preferably occur without breaching the sterilized packaging.
  • Further disclosed are apparatus for stabilizing a sensor that is in use. These apparatus include a circuit connectable to the sensor that provides a signal to the sensor that prevents the sensor from becoming destabilized when disconnected from a monitoring device. Such a circuit can prevent a sensor from becoming depolarized by, for example, providing an appropriate electrical current or potential. These apparatus can also include a rechargeable voltage source and/or a recordable storage medium that is capable of recording data related to a sensor.
  • DESCRIPTION OF DRAWINGS
  • FIG. 1 is an illustration of an electrochemical sensor.
  • FIG. 1A is a schematic of a circuit.
  • FIG. 2 is a cross-sectional view of the working electrode of the electrochemical sensor of FIG. 1.
  • FIG. 3 is a perspective view of a sterilizable packaging in the form of a sealable pouch.
  • FIG. 4 is a rupturable solution container in the shape of a cylinder.
  • FIG. 5 is a cut away view of a sealable pouch with an alternative embodiment of a rupturable solution container that is partially formed using the back portion of the sealable pouch.
  • FIG. 6 is a cut away view of a sealable pouch containing a sensor connected to a circuit capable of exciting the sensor.
  • FIG. 7 is a cut away view of a sealable pouch containing a sensor connected to a circuit capable of exciting the sensor and a rupturable solution container.
  • FIG. 8 is a block diagram showing a configuration of a sensor connected in series to a circuit then to a monitoring device.
  • FIG. 9 is a block diagram showing an alternative configuration of the circuit connected to the sensor and monitoring device connected to the sensor not in series.
  • FIG. 10 is a block diagram showing an alternative configuration with the circuit and the sensor integrated into a single unit and connected to a patient monitoring cable and a monitoring device in series.
  • FIG. 11 is a block diagram showing an alternative configuration with the circuit integrated into a patient monitoring cable such that the circuit is not removed when the sensor is in use.
  • FIG. 12 is a block diagram showing an alternative configuration with the circuit removeably connectable to a patient monitoring cable.
  • FIG. 13 is a block diagram showing an alternative configuration with the circuit housed in a module to which the sensor and monitoring device can be connected.
  • Like reference numerals and symbols in the various drawings indicate like elements.
  • DETAILED DESCRIPTION
  • Apparatus and methods for preparing and maintaining sensors for use are disclosed herein. The apparatus and methods for preparing sensors for use are utilized in advance of the sensor being removed from a sealed sterilized package. The apparatus include packaging materials having electrical circuits capable of stabilizing a sensor to prepare the sensor for use. The methods for preparing a sensor for use include methods of providing a solution to a sterilized packaging that contains a sensor and activating a circuit electrically connected to the sensor. These methods can be performed without compromising the sterilized packaging and allow time for the sensor to stabilize.
  • Further disclosed herein are apparatus for stabilizing a sensor that is in use. These apparatus include a circuit connectable to the sensor that provides a signal to the sensor that prevents the sensor from becoming destabilized when disconnected from a monitoring device. A circuit for stabilizing a sensor during use can be similar to or the same as a circuit for preparing a sensor for use.
  • As shown in FIG. 1, a sensor 10 for measuring an analyte includes a reference electrode 20, an optional counter electrode 30, and a working electrode 40 provided on a substrate 50. The electrodes (20, 30, 40) are formed of a conductive material. The reference electrode 20 can be, for example, an Ag/AgCl electrode. The counter electrode 30 and working electrode 40 can be, for example, graphite and platinum. In operation, the reference electrode 20 establishes a fixed potential from which the potential of the counter electrode 30 and working electrode 40 can be established. The counter electrode 30 provides a working area for conducting the majority of electrons from, for example, an oxidation reaction back to the solution being analyzed, i.e., blood. Otherwise the current generated from the chemical reaction would pass through the reference electrode 20 and possibly reduce its service life. Electrically conductive wires 60 are connected to the reference electrode 20 and working electrode 40 for applying and/or measuring current or potential at or between the electrodes. Although the sensor 10 shown in FIG. 1 includes one reference electrode 20, one counter electrode 30, and one working electrode 40, electrochemical sensors can include multiple reference electrodes, counter electrodes, and working electrodes as would be understood by one of skill in the art.
  • The electrically conductive wires 60 can be connected to a circuit. An example of a circuit 62 is shown in FIG. 1A. A circuit 62 can include a parallel resistor 64 to limit voltage drop, a switch 66, and a voltage source 68 such as a battery, as shown in FIG. 1A. Such a circuit 62 can be a current controlled voltage source that provides a constant voltage. An example of a range of voltages for use in such a circuit 62 is about 0.2 V to about 2 V, other ranges of voltages include about 0.4 V to about 1.5 V, about 0.5 V to about 1 V, and about 0.6 V to about 0.7 V. Other circuit designs that provide a current controlled voltage source that provides a constant voltage will be apparent to one of skill in the art. For example, other electrical components can be used instead of or with the parallel resistor 64 such as a capacitor to help control the voltage of the circuit.
  • FIG. 2 shows a cross-section of the area enclosed by the dashed area 55 in FIG. 1. In FIG. 2, the working electrode 40 is covered by an analyte selective membrane 70 which also covers a reagent layer 80. Reagent layer 80 is selected to react with one or more specific analytes found or expected to be found in a fluid to be analyzed. For example, in a glucose biosensor, the reagent layer 80 can contain glucose oxidase, such as may be derived from Aspergillus niger (EC 1.1.3.4), type II or type VII. Reagent layer 80 can also include a matrix such as a hydrogel to promote a reaction between the reagent and an analyte that passes through the membrane 70. A hydrogel, for example, can be water absorbent and swell to provide active transport of an analyte in a fluid under analysis (e.g., glucose) from the fluid into the reagent layer 80.
  • An apparatus for preparing a sensor for use in advance of the sensor being removed from a sealed sterilized package is shown in FIG. 3. FIG. 3 is a perspective view of a sterilizable packaging in the form of a sealable pouch 100. Although FIG. 3 illustrates a sealable pouch 100, any other form of sterilizable packaging can be used in accordance with the invention. The sealable pouch 100 is made of a material such as a polymer that can maintain a sterilized environment and is typically liquid and vapor impermeable. The sealable pouch 100 is referred to as being sealable rather than sealed because, as depicted, one end 110 is open. The sealable pouch 100 can be sealed using an adhesive composition or heat sealing (melting) in the case of a polymer. Techniques for sealing sterilized containers are well known to those of skill in the art. The sealable pouch 100 can be made from flexible materials or a mixture of flexible, rigid, or substantially rigid materials. For example, the sealable pouch could include a rigid back portion, i.e., a rigid backing, and a flexible front portion.
  • Also shown in FIG. 3 is a resealable portion 112. The resealable portion 112 can be used to provide solution to the sealable pouch 100. The resealable portion 112 can for example be a self-sealing membrane 114 through which a syringe can be inserted. Alternatively, or in addition to the resealable portion 112 is shown a partial view of a rupturable solution container 120 that is inserted into the sealable pouch 100. The rupturable solution container 120 is also shown in FIG. 4. As shown, the rupturable solution container 120 is cylindrical, though other shapes and configurations are possible. Additionally, the size of the rupturable solution container 120 can be varied to accommodate the volume of solution desired to be delivered to the sealable pouch 100.
  • The rupturable solution container 120 is made from a material, such as a polymer, that is more easily ruptured than the material used to make the sealable pouch 100. A more easily ruptured material is used so the rupturable solution container 120 can be ruptured while on the interior of the sealable pouch 100 using forces that will not breach the sealable pouch 100. For example, the sealable pouch 100 will not be breached at any point along the material used to form the sealable pouch 100 or any point where two or more portions of the sealable pouch 100 are sealed together, e.g., along a seam, when the rupturable container is ruptured. The ability to maintain the integrity of the sealable pouch 100 allows the maintenance of a sterilized state for any contents of the sealable pouch 100. The rupturable solution container 120 can be attached to an inner portion of the sealable pouch 100 through the use, for example, of an adhesive or by forming the rupturable solution container as part of the sealable pouch. Attaching the rupturable solution container 120 to an inner portion of the sealable pouch 100 can provide consistency in the positioning of the rupturable solution container 120 for ease of use. The terms rupture and breach and their derivatives are used herein to indicate that a container has been opened such that the contents of a container are able to move from the interior of the container to the exterior of the container. It is noted that the solution can be provided in the rupturable solution container 120 when the sealable pouch 100 is sealed and shipped and/or stored, or the sealable pouch can be sealed and the rupturable solution container filled through the use of a resealable portion 112 and a syringe as discussed above.
  • An alternative design for the rupturable solution container 130 is shown in FIG. 5. In FIG. 5, a rupturable solution container 130 is shown in which a portion of the rupturable solution container 130 is formed by an interior surface 140 of the sealable pouch 100. A seal 150 between the perimeter 160 of the rupturable solution container 130 and the interior surface 140 of the sealable pouch 100 attaches the rupturable solution container 130 to the interior surface 140 of the sealable pouch 100 and prevents solution from leaking prematurely from the rupturable solution container 130. In this embodiment of a rupturable solution container 130, the more easily ruptured material is used to form the interior side 170 of the rupturable solution container 130, which ruptures prior to a breach of the material used to form the sealable pouch 100 to allow the solution into the sealable pouch 100.
  • The types of polymers or other materials for use in such containers can include, for example, polypropylene or polyethylene film or sheet. The tear strength, i.e., the resistance of a material to tear forces (as might be measured by ASTM D 1922), is a relevant property for the apparatus and methods described herein. For example, the relative tear strengths of the materials used for the rupturable solution container 120 and the sealable pouch 100 are important in determining the material for use as the rupturable solution container 120 in that the tear strength of the material for use as the rupturable solution container 120 will be less than the tear strength of the sealable pouch 100.
  • The sealable pouch 100 described herein can be used to contain a sensor such as an electrochemical sensor. An example of an electrochemical sensor is a blood glucose sensor. The run-in period for a sensor located in a sealable pouch 100 as described herein that has a sensor sealed inside can be begun by providing an electrolytic, i.e., conductive, solution to the sealable pouch 100. The electrolytic solution can be medically safe and non-toxic, e.g., sterile saline. The electrolytic solution can be provided from an external source or contained, for example, in a rupturable solution container 120, which can provide solution to the sealable pouch 100 when ruptured. As used herein, run-in time is the time it takes for the sensor to reach equilibrium and to be ready for measurement. Once the electrolytic solution is provided or the rupturable solution container 120 is breached, the solution can spread into the sealable pouch 100 and contact the sensor. Electrolytic solution can be provided, for example, by introducing a solution through a resealable portion of the sealable pouch, such as, for example, by injection through the resealable membrane 114.
  • Once contacted by the solution, the run-in period can begin with respect to, for example, hydration. Run-in time can be considered to include multiple phases such as hydration (i.e., the time for the sensor to come into contact and equilibrate with a solution) and polarization (i.e., the time for the sensor to stabilize once voltage is applied to the sensor). These phases can occur simultaneously or overlap. If aspects of the sensor other than hydration remain to be activated or run-in after exposure to the solution, such as aspects of the sensor that are dependent on the presence of an electric potential, these aspects for preparing the electrode can then be performed after the solution is added. If the circuit is connected to the sensor prior to the addition of solution, both hydration and electrical stabilization can begin as soon as the system comes into contact with the electrolytic solution. Electrical stabilization of the sensor can include non-Faradaic responses.
  • To run-in the electrical aspects of a sensor contained in a sealable pouch 100, a sensor can be connected to a circuit designed to excite the sensor, such as, for example, the circuit shown in FIG. 1A. As shown in FIG. 6, a sensor 200 can be electrically connected to a circuit capable of exciting the sensor 300 with both the sensor 200 and circuit capable of electrically exciting the sensor 300 located within the sealable pouch 100. The circuit 300 can be provided in the sterilized sealable pouch 100 and can be activated within the sealable pouch 100 without exposing the sensor 200 to the outside environment. The circuit capable of electrically exciting the sensor 300 can be manually activated through the use of a force external to the sealable pouch 100 such as by the activation of a switch, remotely activated through the use of an external signal, or automatically activated upon the provision of a solution to the sealable pouch 100. For example, an electrical connection for activating the circuit 300 can be provided on a surface of the sealable pouch 100 and manually activated without opening the pouch or a complete circuit can be integrated into the sealable pouch 100 that is activated upon the provision of an electrolytic solution. As used herein, the phrase “excite the sensor” refers to providing an electrical signal to the sensor 200 such that the sensor achieves, remains at or close to, or approaches a condition at which it can take sensor readings with little or no additional electrical preparation. Such an electrical signal can include, for example, a current controlled constant or periodic potential provided by, for example, a current controlled voltage source that provides a constant voltage, which is applied to a reference electrode 12 and/or a working electrode 16 such as those shown in FIG. 3. The number and type of electrical signals can depend on the number and state the electrodes will need to be in when the sensor 300 is used for sensing. FIG. 7 shows an embodiment in which a circuit capable of electrically exciting the sensor 300 and alternatively a resealable portion 112 and/or a rupturable solution container 120 are included in a sealable pouch 100. In this embodiment, the circuit capable of electrically exciting the sensor 300 can be activated at or around the time the rupturable solution container 120 is ruptured through, for example, the use of a fluid sensor located within the pouch.
  • Methods for preparing a sensor for use include providing a solution such as an electrolytic solution to a sterilized packaging containing a sensor without compromising the sterilizable packaging then allowing the sensor to stabilize in the solution. The sensor can be connected to a sensor activating circuit before or after the provision of the electrolytic solution. If the sensor is connected to a sensor activating circuit after solution is provided, the sensor activating circuit can be activated and the electrical aspects of the system can be run-in. The circuit can be activated by an external force, such as moving a switch, or automatically when the solution is provided. For example, solution can be provided and a switch activated to initiate the sensor activating circuit. For further example, solution can be provided and the sensor activating circuit can be activated by the presence of solution. Such sensors are described above and can include a glucose sensor. Examples of solutions for use with the apparatus and methods herein include, but are not limited to, buffer solutions, saline solutions, solutions containing electrolytes or other chemicals needed either for chemical reactions at the electrodes or for other electrode preparations, and mixtures thereof.
  • The several sensor run-in preparations described herein may or may not completely prepare a sensor for use. However, the sensor will be closer to an operational state than if the run-in preparations did not occur. When a glucose sensor, for example, is in use, hydrogen peroxide is produced in the presence of glucose at the electrode, the hydrogen peroxide is converted to electrons, and the electrons are measured at the working electrode. When a glucose sensor is first exposed to glucose there is a lag time before electrons are produced at a steady-state indicating the glucose level. After a steady-state is obtained, if voltage is discontinued to the electrodes, the sensor depolarizes, i.e., electrons are no longer attracted to the working electrode, but the reaction to form hydrogen peroxide still occurs. Thus, when a potential is again applied to the electrodes the excess hydrogen peroxide needs to be converted and the measurement from the sensor will appear higher than the actual glucose level. In both the start up and restart scenarios, the sensor takes some time to equilibrate and provide a steady-state reading indicative of the glucose level.
  • Also provided herein, are apparatus for stabilizing a sensor that is being prepared for use, e.g., during initial implantation, or already in use. These apparatus include a circuit connectable to a sensor for providing a signal, such as an electrical current or potential, to the sensor. Such a signal can include, for example, a constant or periodic potential applied to a reference electrode 12 and/or a working electrode 16 such as those shown in FIG. 3. The signal chosen to be sent to the sensor is one that prevents the sensor from becoming destabilized prior to being connected or upon being disconnected from a monitoring device. For example, the circuit can prevent the sensor from becoming depolarized. When the electrodes of a sensor become depolarized the sensor cannot be used immediately and another run-in period becomes necessary to repolarize the electrodes. A glucose sensor, for example, has a chemical component to maintain a stabilized state, i.e., if a glucose sensor is in the presence of glucose, hydrogen peroxide conversion takes place and excess hydrogen peroxide will need to be converted prior to obtaining accurate glucose level readings. However, if the glucose sensor retains its electrical potential excess hydrogen peroxide does not accumulate at the working electrode.
  • As shown in FIG. 8, a sensor 400 can be connected to a circuit 500 and a monitoring device 600. FIG. 9 shows an alternative configuration in which the circuit 500 and monitoring device 600 are not connected to the sensor 400 in series, i.e., there are two possible connections to the sensor 400. In either configuration, to stabilize a sensor 400, i.e., maintain the sensor 400 in an active, useable state, a signal is continually provided to excite the sensor 400. Maintaining a signal to excite the sensor 400 is accomplished by maintaining a connection with a power source, such as a power source from either the circuit 500 or monitoring device 600. Alternatively, a signal to excite the sensor 400 is provided by another source, such as a battery of a charged capacitor communicating with the sensor 400. As described above, the sensor 400 can be an electrochemical sensor such as a glucose sensor.
  • The circuit 500 can be configured to connect to a sensor 400 continuously such that the circuit 500 is connected to the sensor 400 both when the sensor 400 is connected to and when the sensor 400 is disconnected from a monitoring device 600. Alternatively, a circuit 500 can be configured to be capable of being removed from the sensor 400 when the sensor 400 is connected to a monitoring device 600 or an alternate signal source and reconnected to the sensor 400 when the sensor 400 is to be disconnected from the monitoring device 600, with the provision that a signal to excite the sensor 400 is continually applied to the sensor 400. In a further alternative as shown in FIG. 10, the sensor 400 and circuit 500 are integrated into a single unit. In an additional alternative, the sensor 400 and circuit 500 are integrated into a single unit that is disposable.
  • If the sensor 400 is connected to, for example, a patient monitoring cable 510, the circuit 500 can either be integrated into the cable 510 so it is not removed when the sensor 400 is in use as shown in FIG. 11, or the circuit 500 can be removeably connectable to the patient monitoring cable 510 as shown in FIG. 12. If the circuit 500 is removeably connectable to a patient monitoring cable 510, the monitoring device 600 to which the patient monitoring cable 510 is connected is capable of providing a signal to the sensor 400. Then, when the patient monitoring cable 510 is to be disconnected from the monitoring device 600, the circuit 500 provides a signal to the sensor 400 in the absence of the signal from the monitoring device 600. When the circuit 500 is integrated into a device, such as a patient monitoring cable 510, and the circuit 500 is not disconnected from the sensor 400 when the sensor 400 is connected to a monitoring device 600, the circuit 500 can be configured such that there is a manual mechanism for disconnecting the circuit 500 from the sensor 400 or the circuit 500 can be configured to automatically disconnect in the presence of another signal source, e.g., a voltage source. Alternatively, when the sensor 400 is connected to the monitoring device 600, the circuit 500 can continue to provide a signal to the sensor 400 with the monitoring device 600 providing power for the circuit 500 to operate or charging the power source of the circuit 500. Such circuit aspects are easily designed and implemented by those of skill in the art.
  • As shown in FIG. 13, circuits 500 such as those described can be housed in modules 520 to which a sensor 400 can be connected and which can be in turn connected in series to a monitoring device 600. A monitoring device 600 can be configured to accept a module 520 containing a circuit 500.
  • A circuit 500 can include a rechargeable voltage source, e.g., a rechargeable battery. The circuit 500 can be configured to recharge the rechargeable power source when the circuit is connected to a monitoring device. Alternately, the rechargeable power source can be charged or recharged at a charging station which can be used to initially charge a rechargeable voltage source connected to a circuit 500 or maintain a charge if a sensor 400 remains disconnected from a monitoring device 600 for an extended period of time. A recharging station can have multiple positions for simultaneously charging multiple circuits 500.
  • As an additional feature, a recordable storage medium (not shown) can be included in the circuit 500. The recordable storage medium, such as an electrically erasable programmable read-only memory (EEPROM), can, for example, record data corresponding to the sensor 400. Data corresponding to the sensor 400 can include time data, such as total time in service or time since last connected to a monitoring device 600, calibration data, or sensor reading or condition data. Such data can, for example, be recorded from sensor readings, internal timing devices, or other sensor 400 or circuit 500 generated data, or transferred to the circuit 500 prior to the sensor 400 being disconnected from a monitoring device 600. Then, conversely, when the sensor 400 is connected to a different monitoring device 600, some or all of the data can be transferred to the newly connected (or reconnected) monitoring device 600 to enable the new (or reconnected) monitoring device 600 to prepare the sensor 400 to begin collecting data, thereby reducing the needed run-in and/or calibration time. If a large enough memory capacity is available, all or many of the measurements made by a sensor 400 during a monitoring period could be stored in the circuit 500 for retrieval by a number of different monitors. Further features of the circuit 500 can include the ability to wirelessly transmit data to a monitoring device when a sensor 400 is detached from the monitoring device and the ability to log readings upon disconnect (either accidental or intentional) for transmittal to a monitoring device when reattached.
  • Circuits 500 such as those described can be housed in modules to which a sensor 400 can be connected and which can be in turn connected in series to a monitoring device 600. Such a circuit 500 can also be integrated into a device containing a sensor 400. A monitoring device 600 can be configured to accept a module containing a circuit 500. Further, sensors 400 can, for example, be incorporated into devices including medical devices such as patient monitoring cables. Circuits 500 can be, for example, incorporated into devices incorporating sensors or devices designed to connect to sensors. Where a storage capacitor is used as a signal source as described above, it can also be incorporated into devices in the same manner as the circuit 500.
  • The present invention is not limited in scope by the embodiments disclosed herein which are intended as illustrations of a few aspects of the invention and any embodiments which are functionally equivalent are within the scope of this invention. Various modifications of the apparatus and methods in addition to those shown and described herein will become apparent to those skilled in the art and are intended to fall within the scope of the appended claims. Further, while only certain representative combinations of the apparatus and method steps disclosed herein are specifically discussed in the embodiments above, other combinations of the apparatus components and method steps will become apparent to those skilled in the art and also are intended to fall within the scope of the appended claims. Thus a combination of components or steps may be explicitly mentioned herein; however, other combinations of components and steps are included, even though not explicitly stated. The term “comprising” and variations thereof as used herein is used synonymously with the term “including” and variations thereof and are open, non-limiting terms.

Claims (42)

1. An apparatus comprising:
a sterilizable packaging; and
a sensor stabilizing circuit connectable to the interior of the sterilizable packaging, the circuit capable of stabilizing a sensor.
2. An apparatus as defined in claim 1, wherein the sterilizable packaging is sealed.
3. An apparatus as defined in claim 2, wherein the circuit is capable of being activated without disrupting the seal of the sterilizable packaging.
4. An apparatus as defined in claim 1, further comprising a sensor contained within the sterilizable packaging.
5. An apparatus as defined in claim 4, wherein the sensor is a glucose sensor.
6. An apparatus as defined in claim 1, further comprising a resealable port for the addition of an electrolyte solution.
7. An apparatus as defined in claim 4, further comprising a rupturable solution container located within the sterilizable packaging.
8. An apparatus as defined in claim 7, wherein the rupturable solution container is attached to an interior portion of the sterilizable packaging.
9. An apparatus as defined in claim 7, wherein a portion of the rupturable solution container is formed by the sterilizable packaging.
10. An apparatus comprising:
a sterilized packaging;
a sensor, the sensor sealed within the sterilized packaging; and
a circuit electrically connected to the sensor, the circuit capable of exciting the sensor.
11. An apparatus as defined in claim 10, wherein the circuit is capable of being activated without disrupting the seal of the sterilizable packaging.
12. An apparatus as defined in claim 10, further comprising a resealable port for the addition of an electrolyte solution.
13. An apparatus as defined in claim 12, wherein the resealable port is a self-sealing membrane.
14. An apparatus as defined in claim 10, further comprising a rupturable solution container located within the sterilized packaging.
15. An apparatus as defined in claim 14, wherein the rupturable solution container is attached to an interior portion of the sterilizable packaging.
16. An apparatus as defined in claim 14, wherein a portion of the rupturable solution container is formed by the sterilizable packaging.
17. An apparatus as defined in claim 10, wherein the circuit is activated by a force external to the sterilized packaging.
18. An apparatus as defined in claim 10, wherein the sensor is a glucose sensor.
19. A method of preparing a sensor for use comprising:
providing an electrolyte solution to a sterilized packaging containing a sensor connected to a sensor activating circuit without compromising the sterilizable packaging;
activating the sensor activating circuit; and
allowing the sensor to stabilize in the electrolyte solution.
20. The method of claim 19, wherein the sensor is a glucose sensor.
21. The method of claim 19, wherein the electrolyte solution is provided via a resealable port in the sterilized packaging.
22. The method of claim 19, wherein the electrolyte solution is provided via a rupturable solution container.
23. The method of claim 19, wherein the circuit is activated when the electrolyte solution is provided.
24. An apparatus for stabilizing a sensor comprising:
a circuit connectable to a sensor, the circuit providing a signal to the sensor that prevents the sensor from becoming destabilized when disconnected from a monitoring device.
25. An apparatus as defined in claim 24, wherein the circuit prevents the sensor from becoming depolarized.
26. An apparatus as defined in claim 24, wherein the sensor is a glucose sensor.
27. An apparatus as defined in claim 24, wherein the apparatus is incorporated into the sensor.
28. An apparatus as defined in claim 24, wherein the signal is an electrical current or potential.
29. An apparatus as defined in claim 24, further comprising an internal power source.
30. An apparatus as defined in claim 29, wherein the internal power source is rechargeable.
31. An apparatus as defined in claim 29, wherein the internal power source is a battery.
32. An apparatus as defined in claim 24, further comprising a timing device.
33. An apparatus as defined in claim 32, wherein the timing device is a clock.
34. An apparatus as defined in claim 24, further comprising a recordable storage medium capable of recording data for the sensor.
35. An apparatus as defined in claim 34, wherein the recordable storage medium is electrically erasable programmable read-only memory.
36. An apparatus as defined in claim 34, wherein the data is transmitted between a monitoring unit and the circuit when the sensor is connected to the monitoring unit.
37. An apparatus as defined in claim 34, wherein the data is generated by an internal timing device.
38. An apparatus as defined in claim 34, wherein the data is generated by the sensor.
39. An apparatus as defined in claim 24, further comprising a wireless communication device for communicating with a monitoring device.
40. An apparatus as defined in claim 39, wherein calibration data is transferred between the circuit and the monitoring device.
41. An apparatus as defined in claim 24, further comprising a recordable storage medium capable of recording sensor readings.
42. An apparatus as defined in claim 41, wherein the recordable storage medium records the readings of the sensor.
US12/276,230 2007-11-28 2008-11-21 Preparation and maintenance of sensors Abandoned US20090188811A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US12/276,230 US20090188811A1 (en) 2007-11-28 2008-11-21 Preparation and maintenance of sensors
CA2706592A CA2706592A1 (en) 2007-11-28 2008-11-24 Conditioning of a packaged glucose sensor
AT08857379T ATE545861T1 (en) 2007-11-28 2008-11-24 CONDITIONING A PACKAGED GLUCOSE SENSOR
KR1020107014075A KR20100103534A (en) 2007-11-28 2008-11-24 Conditioning of a packaged glucose sensor
EP11194971.5A EP2434277B1 (en) 2007-11-28 2008-11-24 Conditioning of a packaged glucose sensor
CN201310375802.6A CN103529094A (en) 2007-11-28 2008-11-24 Conditioning of a packaged glucose sensor
EP08857379A EP2223094B1 (en) 2007-11-28 2008-11-24 Conditioning of a packaged glucose sensor
PCT/US2008/084568 WO2009073450A1 (en) 2007-11-28 2008-11-24 Conditioning of a packaged glucose sensor
CN200880125648.4A CN101925811B (en) 2007-11-28 2008-11-24 Conditioning of packaged glucose sensor
US13/430,492 US8834703B2 (en) 2007-11-28 2012-03-26 Preparation and maintenance of sensors
US14/459,643 US20140353153A1 (en) 2007-11-28 2014-08-14 Preparation and Maintenance of Sensors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99079707P 2007-11-28 2007-11-28
US12/276,230 US20090188811A1 (en) 2007-11-28 2008-11-21 Preparation and maintenance of sensors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/430,492 Continuation US8834703B2 (en) 2007-11-28 2012-03-26 Preparation and maintenance of sensors

Publications (1)

Publication Number Publication Date
US20090188811A1 true US20090188811A1 (en) 2009-07-30

Family

ID=40428115

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/276,230 Abandoned US20090188811A1 (en) 2007-11-28 2008-11-21 Preparation and maintenance of sensors
US13/430,492 Active US8834703B2 (en) 2007-11-28 2012-03-26 Preparation and maintenance of sensors
US14/459,643 Abandoned US20140353153A1 (en) 2007-11-28 2014-08-14 Preparation and Maintenance of Sensors

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/430,492 Active US8834703B2 (en) 2007-11-28 2012-03-26 Preparation and maintenance of sensors
US14/459,643 Abandoned US20140353153A1 (en) 2007-11-28 2014-08-14 Preparation and Maintenance of Sensors

Country Status (7)

Country Link
US (3) US20090188811A1 (en)
EP (2) EP2434277B1 (en)
KR (1) KR20100103534A (en)
CN (2) CN101925811B (en)
AT (1) ATE545861T1 (en)
CA (1) CA2706592A1 (en)
WO (1) WO2009073450A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200096470A1 (en) * 2017-03-22 2020-03-26 Aalto University Foundation Sr Electrochemical assay for the detection of opioids

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2607276B (en) * 2021-05-10 2023-08-16 Vestlandets Innovasjonsselskap As Intestinal capsule assembly

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271278A (en) * 1978-10-16 1981-06-02 Medtronic, Inc. Cathode materials
US4398346A (en) * 1981-10-23 1983-08-16 Medtronic, Inc. Method for lithium anode and electrochemical cell fabrication
US4430397A (en) * 1981-07-06 1984-02-07 Medtronic, Inc. Electrochemical cells
US4465743A (en) * 1982-12-15 1984-08-14 Medtronic, Inc. Electrochemical cells having lithium tetrachloroiodate cathodes
US4608322A (en) * 1983-09-29 1986-08-26 Medtronic, Inc. Nonaqueous electrochemical cell
US4937444A (en) * 1982-09-29 1990-06-26 Vpl Research, Inc. Optical flex sensor
US4983524A (en) * 1986-12-19 1991-01-08 Suntory Limited Method of immobilizing enzymes on a support with iridoid aglycone cross-linking agents
US5178267A (en) * 1990-12-20 1993-01-12 Abbott Laboratories Packaging system for a sterilizable calbratable medical device
US5229282A (en) * 1989-11-24 1993-07-20 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system
US5278200A (en) * 1992-10-30 1994-01-11 Medtronic, Inc. Thromboresistant material and articles
US5328848A (en) * 1988-07-25 1994-07-12 Abbott Laboratories Method for hydrating and calibrating a sterilizable fiber-optic catheter
US5331966A (en) * 1991-04-05 1994-07-26 Medtronic, Inc. Subcutaneous multi-electrode sensing system, method and pacer
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5421981A (en) * 1991-06-26 1995-06-06 Ppg Industries, Inc. Electrochemical sensor storage device
US5423883A (en) * 1993-07-14 1995-06-13 Pacesetter, Inc. Implantable myocardial stimulation lead with sensors thereon
US5429735A (en) * 1994-06-27 1995-07-04 Miles Inc. Method of making and amperometric electrodes
US5434017A (en) * 1993-11-19 1995-07-18 Medtronic, Inc. Isolated connection for an electrochemical cell
US5439760A (en) * 1993-11-19 1995-08-08 Medtronic, Inc. High reliability electrochemical cell and electrode assembly therefor
US5482473A (en) * 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5486215A (en) * 1993-11-19 1996-01-23 Medtronic, Inc. Electrode assembly and method
US5538511A (en) * 1994-04-01 1996-07-23 Minimed Inc. Indwelling catheter with stable enzyme coating
US5549985A (en) * 1993-04-27 1996-08-27 Medtronic, Inc. Method of assembling electrochemical cells of novel construction
US5607565A (en) * 1995-03-27 1997-03-04 Coulter Corporation Apparatus for measuring analytes in a fluid sample
US5607463A (en) * 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
US5728420A (en) * 1996-08-09 1998-03-17 Medtronic, Inc. Oxidative method for attachment of glycoproteins to surfaces of medical devices
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5766839A (en) * 1994-06-17 1998-06-16 Ysi Incorporated Processes for preparing barrier layer films for use in enzyme electrodes and films made thereby
US5777060A (en) * 1995-03-27 1998-07-07 Minimed, Inc. Silicon-containing biocompatible membranes
US5779665A (en) * 1997-05-08 1998-07-14 Minimed Inc. Transdermal introducer assembly
US5786439A (en) * 1996-10-24 1998-07-28 Minimed Inc. Hydrophilic, swellable coatings for biosensors
US5891506A (en) * 1996-08-09 1999-04-06 Medtronic, Inc. Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices
US5914179A (en) * 1995-10-03 1999-06-22 Nippon Mektron Ltd. Flexible circuit board and production method therefor
US5919216A (en) * 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
US6038475A (en) * 1995-03-08 2000-03-14 Medtronic, Inc. High output sensor and accelerometer for implantable medical device
US6071391A (en) * 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6093172A (en) * 1997-02-05 2000-07-25 Minimed Inc. Injector for a subcutaneous insertion set
US6093167A (en) * 1997-06-16 2000-07-25 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6093506A (en) * 1997-02-03 2000-07-25 Medtronic, Inc. Synthesis of silver vanadium oxide for cathode material
US6101973A (en) * 1997-09-03 2000-08-15 Medtronic, Inc. Apparatus for reducing friction on polymeric surfaces
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6176988B1 (en) * 1996-05-25 2001-01-23 Manfred Kessler Membrane electrode for measuring the glucose concentration in fluids
US6198952B1 (en) * 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead
US6200265B1 (en) * 1999-04-16 2001-03-13 Medtronic, Inc. Peripheral memory patch and access method for use with an implantable medical device
US6205358B1 (en) * 1997-08-01 2001-03-20 Medtronic, Inc. Method of making ultrasonically welded, staked of swaged components in an implantable medical device
US6212416B1 (en) * 1995-11-22 2001-04-03 Good Samaritan Hospital And Medical Center Device for monitoring changes in analyte concentration
US6218016B1 (en) * 1998-09-29 2001-04-17 Medtronic Ave, Inc. Lubricious, drug-accommodating coating
US6223083B1 (en) * 1999-04-16 2001-04-24 Medtronic, Inc. Receiver employing digital filtering for use with an implantable medical device
US6248067B1 (en) * 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6252032B1 (en) * 1999-07-07 2001-06-26 Minimed Inc. UV absorbing polymer
US6254586B1 (en) * 1998-09-25 2001-07-03 Minimed Inc. Method and kit for supplying a fluid to a subcutaneous placement site
US6261280B1 (en) * 1999-03-22 2001-07-17 Medtronic, Inc Method of obtaining a measure of blood glucose
US6340421B1 (en) * 2000-05-16 2002-01-22 Minimed Inc. Microelectrogravimetric method for plating a biosensor
US6360888B1 (en) * 1999-02-25 2002-03-26 Minimed Inc. Glucose sensor package system
US6368274B1 (en) * 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US20020072084A1 (en) * 2000-11-02 2002-06-13 Meserol Peter M. Biological fluid analysis device
US6413393B1 (en) * 1999-07-07 2002-07-02 Minimed, Inc. Sensor including UV-absorbing polymer and method of manufacture
US6418332B1 (en) * 1999-02-25 2002-07-09 Minimed Test plug and cable for a glucose monitor
US6424847B1 (en) * 1999-02-25 2002-07-23 Medtronic Minimed, Inc. Glucose monitor calibration methods
US6512939B1 (en) * 1997-10-20 2003-01-28 Medtronic Minimed, Inc. Implantable enzyme-based monitoring systems adapted for long term use
USD469540S1 (en) * 1999-02-25 2003-01-28 Medtronic Minimed, Inc. Glucose sensor
US6560471B1 (en) * 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6558734B2 (en) * 2001-02-09 2003-05-06 Medtronic, Inc. Methods for modifying surfaces of articles
US6558351B1 (en) * 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6572748B1 (en) * 1998-03-10 2003-06-03 Micronas Gmbh Reference electrode
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US6577899B2 (en) * 2000-01-21 2003-06-10 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6592746B1 (en) * 1998-04-14 2003-07-15 The Regents Of The University Of California Sensor probe for determining hydrogen peroxide concentration and method of use thereof
US20040058453A1 (en) * 2002-09-20 2004-03-25 3M Innovative Properties Company Reaction pouch comprising an analytical sensor
US6731976B2 (en) * 1997-09-03 2004-05-04 Medtronic, Inc. Device and method to measure and communicate body parameters
US20040137633A1 (en) * 2002-07-26 2004-07-15 Instrumentation Laboratory Company Aqueous solutions for reducing the rate of oxygen loss, and methods thereof
US6895263B2 (en) * 2000-02-23 2005-05-17 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US6895265B2 (en) * 2000-05-15 2005-05-17 James H. Silver Implantable sensor
US6899813B2 (en) * 1996-04-30 2005-05-31 Medtronic, Inc. Method for the production of a blood component composition
US6908535B2 (en) * 2002-03-06 2005-06-21 Medtronic, Inc. Current-to-voltage-converter for a biosensor
US6915147B2 (en) * 2001-09-07 2005-07-05 Medtronic Minimed, Inc. Sensing apparatus and process
US6922330B2 (en) * 2002-04-18 2005-07-26 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor fabricated with laser welded anode sheets
US6985764B2 (en) * 2001-05-03 2006-01-10 Masimo Corporation Flex circuit shielded optical sensor
US6991096B2 (en) * 2002-09-27 2006-01-31 Medtronic Minimed, Inc. Packaging system
US7003336B2 (en) * 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
US7003340B2 (en) * 1998-03-04 2006-02-21 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US7006858B2 (en) * 2000-05-15 2006-02-28 Silver James H Implantable, retrievable sensors and immunosensors
US7018336B2 (en) * 2001-12-27 2006-03-28 Medtronic Minimed, Inc. Implantable sensor flush sleeve
US7022072B2 (en) * 2001-12-27 2006-04-04 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US7241266B2 (en) * 2004-05-20 2007-07-10 Digital Angel Corporation Transducer for embedded bio-sensor using body energy as a power source
US20080033264A1 (en) * 2004-11-23 2008-02-07 Torsten Lonneker-Lammers Pulsoximetry Measuring Device
US20080029390A1 (en) * 2006-02-27 2008-02-07 Joelle Roche Hydrogel for an intravenous amperometric biosensor
US20080125751A1 (en) * 2002-01-14 2008-05-29 Edwards Lifesciences Corporation Temperature compensation for enzyme electrodes

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223110A (en) 1978-10-16 1980-09-16 Medtronic, Inc. Cathode materials
US4352360A (en) 1981-03-30 1982-10-05 Medtronic, Inc. Semiconductor low-threshhold electrode
US4542291A (en) 1982-09-29 1985-09-17 Vpl Research Inc. Optical flex sensor
US4549952A (en) 1982-11-22 1985-10-29 Eastman Kodak Company Capillary transport device having means for increasing the viscosity of the transported liquid
US4703756A (en) * 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4726381A (en) * 1986-06-04 1988-02-23 Solutech, Inc. Dialysis system and method
US5352348A (en) 1987-04-09 1994-10-04 Nova Biomedical Corporation Method of using enzyme electrode
JPS63300953A (en) * 1987-05-29 1988-12-08 Daikin Ind Ltd Sensor unit
US4991290A (en) 1988-07-21 1991-02-12 Microelectronics And Computer Technology Flexible electrical interconnect and method of making
US4863016A (en) 1988-07-25 1989-09-05 Abbott Laboratories Packaging for a sterilizable calibratable medical device
US5165407A (en) 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
DE4405149C2 (en) * 1993-02-25 1998-11-26 Daimler Benz Aerospace Ag Arrangement for determining the concentration of ingredients in body fluids
US5455123A (en) 1994-02-14 1995-10-03 Medtronic, Inc. Method for making an electrochemical cell
US5419977A (en) 1994-03-09 1995-05-30 Medtronic, Inc. Electrochemical device having operatively combined capacitor
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5458997A (en) 1994-08-19 1995-10-17 Medtronic, Inc. Rebalancing of lithium/silver vandium oxide (Li/SVO) cells for improved performance
US5697367A (en) 1994-10-14 1997-12-16 Somanetics Corporation Specially grounded sensor for clinical spectrophotometric procedures
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US5568806A (en) 1995-02-16 1996-10-29 Minimed Inc. Transcutaneous sensor insertion set
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US5987361A (en) 1996-03-07 1999-11-16 Axon Engineering, Inc. Polymer-metal foil structure for neural stimulating electrodes
JP2910670B2 (en) 1996-04-12 1999-06-23 日本電気株式会社 Semiconductor mounting structure
US6125291A (en) 1998-10-30 2000-09-26 Medtronic, Inc. Light barrier for medical electrical lead oxygen sensor
US6144866A (en) 1998-10-30 2000-11-07 Medtronic, Inc. Multiple sensor assembly for medical electric lead
US6134459A (en) 1998-10-30 2000-10-17 Medtronic, Inc. Light focusing apparatus for medical electrical lead oxygen sensor
US5994444A (en) 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6119028A (en) 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
CA2575064C (en) 1997-12-31 2010-02-02 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
GB9801286D0 (en) 1998-01-21 1998-03-18 Univ Cambridge Tech Sensor
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6118652A (en) 1998-04-03 2000-09-12 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor with laser welded cover
US5992211A (en) 1998-04-23 1999-11-30 Medtronic, Inc. Calibrated medical sensing catheter system
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US5951521A (en) 1998-09-25 1999-09-14 Minimed Inc. Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site
US6163723A (en) 1998-10-22 2000-12-19 Medtronic, Inc. Circuit and method for implantable dual sensor medical electrical lead
US6303179B1 (en) 1999-02-08 2001-10-16 Medtronic, Inc Method for attachment of biomolecules to surfaces through amine-functional groups
US6143354A (en) 1999-02-08 2000-11-07 Medtronic Inc. One-step method for attachment of biomolecules to substrate surfaces
USD433755S (en) 1999-02-25 2000-11-14 Minimed Inc. Glucose sensor
US6129742A (en) 1999-03-31 2000-10-10 Medtronic, Inc. Thin film resistor for use in medical devices and method of making same
US6295473B1 (en) 1999-04-16 2001-09-25 Medtronic, Inc. Digital delay line receiver for use with an implantable medical device
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6274265B1 (en) 1999-07-21 2001-08-14 Medtronic, Inc. Method and system for evaluating an electrochemical cell for use with an implantable medical device
US6456875B1 (en) 1999-10-12 2002-09-24 Medtronic, Inc. Cyclic redundancy calculation circuitry for use in medical devices and methods regarding same
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US6484045B1 (en) 2000-02-10 2002-11-19 Medtronic Minimed, Inc. Analyte sensor and method of making the same
US6292697B1 (en) 2000-02-15 2001-09-18 Medtronic, Inc. Testing sterile packaged components of an implantable medical device prior to chronic implantation
US6438407B1 (en) 2000-03-20 2002-08-20 Medtronic, Inc. Method and apparatus for monitoring physiologic parameters conjunction with a treatment
US6605039B2 (en) 2000-07-24 2003-08-12 Medtronic, Inc. Cell-based biosensors suitable for implantable medical device applications
US6642015B2 (en) 2000-12-29 2003-11-04 Minimed Inc. Hydrophilic polymeric material for coating biosensors
US6666821B2 (en) 2001-01-08 2003-12-23 Medtronic, Inc. Sensor system
US6960466B2 (en) 2001-05-31 2005-11-01 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
US6872297B2 (en) * 2001-05-31 2005-03-29 Instrumentation Laboratory Company Analytical instruments, biosensors and methods thereof
WO2002102224A2 (en) 2001-06-18 2002-12-27 Given Imaging Ltd. In vivo sensing device with a circuit board having rigid sections and flexible sections
US6671554B2 (en) 2001-09-07 2003-12-30 Medtronic Minimed, Inc. Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same
US6923936B2 (en) 2001-10-23 2005-08-02 Medtronic Minimed, Inc. Sterile device and method for producing same
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US6885107B2 (en) 2002-08-29 2005-04-26 Micron Technology, Inc. Flip-chip image sensor packages and methods of fabrication
US7842234B2 (en) * 2002-12-02 2010-11-30 Epocal Inc. Diagnostic devices incorporating fluidics and methods of manufacture
JP4188847B2 (en) * 2003-01-14 2008-12-03 富士フイルム株式会社 Analytical cartridge
JP2004294605A (en) 2003-03-26 2004-10-21 Fujitsu Display Technologies Corp Liquid crystal panel
US7279174B2 (en) 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
US20080200788A1 (en) 2006-10-04 2008-08-21 Dexcorn, Inc. Analyte sensor
US20050173316A1 (en) 2004-02-03 2005-08-11 Gene Pleus Filtering cell with compound slope
WO2006005033A2 (en) 2004-06-29 2006-01-12 Nuelight Corporation System and method for a high-performance display device having individual pixel luminance sensing and control
CN101057142A (en) * 2004-10-11 2007-10-17 Cypak股份公司 A single use, self-contained assay device for quantitative and qualitative measurements
US20060282001A1 (en) 2005-06-09 2006-12-14 Michel Noel Physiologic sensor apparatus
CN101360992B (en) 2006-02-27 2013-02-20 爱德华兹生命科学公司 Method and apparatus for using flex circuit technology to create a reference electrode channel
CA2630533A1 (en) 2006-02-27 2007-09-07 Edwards Lifesciences Corporation Catheter with integral biosensor
EP2131635A1 (en) 2006-02-27 2009-12-09 Edwards Lifesciences Corporation Active electrode and method for manufacturing it using flex circuit technology
CN101360450A (en) 2006-02-27 2009-02-04 爱德华兹生命科学公司 Flux limiting membrane for intravenous amperometric biosensor
WO2007124448A2 (en) * 2006-04-20 2007-11-01 Rosero Spencer Z Method and apparatus for the management of diabetes
DE202006016617U1 (en) 2006-10-25 2007-01-04 Schramm, Werner, Dr.-Ing. Device for measuring the energy metabolism of living tissue by laser spectroscopy comprises a laser and an optoelectronic unit connected to a probe and an analysis and display unit through disconnectable interfaces
US20090018426A1 (en) 2007-05-10 2009-01-15 Glumetrics, Inc. Device and methods for calibrating analyte sensors
US7827845B2 (en) 2007-06-18 2010-11-09 Codman & Shurtleff, Inc. Method and kit for maintaining a sterile environment during calibration of a medical device

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271278A (en) * 1978-10-16 1981-06-02 Medtronic, Inc. Cathode materials
US4430397A (en) * 1981-07-06 1984-02-07 Medtronic, Inc. Electrochemical cells
US4398346A (en) * 1981-10-23 1983-08-16 Medtronic, Inc. Method for lithium anode and electrochemical cell fabrication
US4937444A (en) * 1982-09-29 1990-06-26 Vpl Research, Inc. Optical flex sensor
US4465743A (en) * 1982-12-15 1984-08-14 Medtronic, Inc. Electrochemical cells having lithium tetrachloroiodate cathodes
US4608322A (en) * 1983-09-29 1986-08-26 Medtronic, Inc. Nonaqueous electrochemical cell
US4983524A (en) * 1986-12-19 1991-01-08 Suntory Limited Method of immobilizing enzymes on a support with iridoid aglycone cross-linking agents
US5328848A (en) * 1988-07-25 1994-07-12 Abbott Laboratories Method for hydrating and calibrating a sterilizable fiber-optic catheter
US5229282A (en) * 1989-11-24 1993-07-20 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system
US5178267A (en) * 1990-12-20 1993-01-12 Abbott Laboratories Packaging system for a sterilizable calbratable medical device
US5331966A (en) * 1991-04-05 1994-07-26 Medtronic, Inc. Subcutaneous multi-electrode sensing system, method and pacer
US5421981A (en) * 1991-06-26 1995-06-06 Ppg Industries, Inc. Electrochemical sensor storage device
US5278200A (en) * 1992-10-30 1994-01-11 Medtronic, Inc. Thromboresistant material and articles
US5607463A (en) * 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
US5549985A (en) * 1993-04-27 1996-08-27 Medtronic, Inc. Method of assembling electrochemical cells of novel construction
US5423883A (en) * 1993-07-14 1995-06-13 Pacesetter, Inc. Implantable myocardial stimulation lead with sensors thereon
US5486215A (en) * 1993-11-19 1996-01-23 Medtronic, Inc. Electrode assembly and method
US5434017A (en) * 1993-11-19 1995-07-18 Medtronic, Inc. Isolated connection for an electrochemical cell
US5439760A (en) * 1993-11-19 1995-08-08 Medtronic, Inc. High reliability electrochemical cell and electrode assembly therefor
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5538511A (en) * 1994-04-01 1996-07-23 Minimed Inc. Indwelling catheter with stable enzyme coating
US5788678A (en) * 1994-04-01 1998-08-04 Minimed Inc. Indwelling catheter with stable enzyme coating
US5482473A (en) * 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5766839A (en) * 1994-06-17 1998-06-16 Ysi Incorporated Processes for preparing barrier layer films for use in enzyme electrodes and films made thereby
US5429735A (en) * 1994-06-27 1995-07-04 Miles Inc. Method of making and amperometric electrodes
US6038475A (en) * 1995-03-08 2000-03-14 Medtronic, Inc. High output sensor and accelerometer for implantable medical device
US5607565A (en) * 1995-03-27 1997-03-04 Coulter Corporation Apparatus for measuring analytes in a fluid sample
US5777060A (en) * 1995-03-27 1998-07-07 Minimed, Inc. Silicon-containing biocompatible membranes
US5914179A (en) * 1995-10-03 1999-06-22 Nippon Mektron Ltd. Flexible circuit board and production method therefor
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US6212416B1 (en) * 1995-11-22 2001-04-03 Good Samaritan Hospital And Medical Center Device for monitoring changes in analyte concentration
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
US6899813B2 (en) * 1996-04-30 2005-05-31 Medtronic, Inc. Method for the production of a blood component composition
US6176988B1 (en) * 1996-05-25 2001-01-23 Manfred Kessler Membrane electrode for measuring the glucose concentration in fluids
US5891506A (en) * 1996-08-09 1999-04-06 Medtronic, Inc. Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices
US5728420A (en) * 1996-08-09 1998-03-17 Medtronic, Inc. Oxidative method for attachment of glycoproteins to surfaces of medical devices
US5786439A (en) * 1996-10-24 1998-07-28 Minimed Inc. Hydrophilic, swellable coatings for biosensors
US6093506A (en) * 1997-02-03 2000-07-25 Medtronic, Inc. Synthesis of silver vanadium oxide for cathode material
US6093172A (en) * 1997-02-05 2000-07-25 Minimed Inc. Injector for a subcutaneous insertion set
US5779665A (en) * 1997-05-08 1998-07-14 Minimed Inc. Transdermal introducer assembly
US5919216A (en) * 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
US6093167A (en) * 1997-06-16 2000-07-25 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6558345B1 (en) * 1997-06-16 2003-05-06 Medtronic, Inc. System for delivering insulin
US6205358B1 (en) * 1997-08-01 2001-03-20 Medtronic, Inc. Method of making ultrasonically welded, staked of swaged components in an implantable medical device
US6731976B2 (en) * 1997-09-03 2004-05-04 Medtronic, Inc. Device and method to measure and communicate body parameters
US6101973A (en) * 1997-09-03 2000-08-15 Medtronic, Inc. Apparatus for reducing friction on polymeric surfaces
US6071391A (en) * 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6512939B1 (en) * 1997-10-20 2003-01-28 Medtronic Minimed, Inc. Implantable enzyme-based monitoring systems adapted for long term use
US6017741A (en) * 1997-12-31 2000-01-25 Medtronic, Inc. Periodate oxidative method for attachment and crosslinking of biomolecules to medical device surfaces
US7003340B2 (en) * 1998-03-04 2006-02-21 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US6572748B1 (en) * 1998-03-10 2003-06-03 Micronas Gmbh Reference electrode
US6592746B1 (en) * 1998-04-14 2003-07-15 The Regents Of The University Of California Sensor probe for determining hydrogen peroxide concentration and method of use thereof
US6565509B1 (en) * 1998-04-30 2003-05-20 Therasense, Inc. Analyte monitoring device and methods of use
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US7003341B2 (en) * 1998-04-30 2006-02-21 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods of use
US6254586B1 (en) * 1998-09-25 2001-07-03 Minimed Inc. Method and kit for supplying a fluid to a subcutaneous placement site
US6218016B1 (en) * 1998-09-29 2001-04-17 Medtronic Ave, Inc. Lubricious, drug-accommodating coating
US6198952B1 (en) * 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead
US6248067B1 (en) * 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
USD469540S1 (en) * 1999-02-25 2003-01-28 Medtronic Minimed, Inc. Glucose sensor
US6424847B1 (en) * 1999-02-25 2002-07-23 Medtronic Minimed, Inc. Glucose monitor calibration methods
US6418332B1 (en) * 1999-02-25 2002-07-09 Minimed Test plug and cable for a glucose monitor
US6520326B2 (en) * 1999-02-25 2003-02-18 Medtronic Minimed, Inc. Glucose sensor package system
US6360888B1 (en) * 1999-02-25 2002-03-26 Minimed Inc. Glucose sensor package system
US6261280B1 (en) * 1999-03-22 2001-07-17 Medtronic, Inc Method of obtaining a measure of blood glucose
US6200265B1 (en) * 1999-04-16 2001-03-13 Medtronic, Inc. Peripheral memory patch and access method for use with an implantable medical device
US6223083B1 (en) * 1999-04-16 2001-04-24 Medtronic, Inc. Receiver employing digital filtering for use with an implantable medical device
US6558351B1 (en) * 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6368274B1 (en) * 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US6413393B1 (en) * 1999-07-07 2002-07-02 Minimed, Inc. Sensor including UV-absorbing polymer and method of manufacture
US6252032B1 (en) * 1999-07-07 2001-06-26 Minimed Inc. UV absorbing polymer
US6577899B2 (en) * 2000-01-21 2003-06-10 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US7003336B2 (en) * 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
US6895263B2 (en) * 2000-02-23 2005-05-17 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US7029444B2 (en) * 2000-02-23 2006-04-18 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US6895265B2 (en) * 2000-05-15 2005-05-17 James H. Silver Implantable sensor
US7006858B2 (en) * 2000-05-15 2006-02-28 Silver James H Implantable, retrievable sensors and immunosensors
US6340421B1 (en) * 2000-05-16 2002-01-22 Minimed Inc. Microelectrogravimetric method for plating a biosensor
US20020072084A1 (en) * 2000-11-02 2002-06-13 Meserol Peter M. Biological fluid analysis device
US6560471B1 (en) * 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6558734B2 (en) * 2001-02-09 2003-05-06 Medtronic, Inc. Methods for modifying surfaces of articles
US6985764B2 (en) * 2001-05-03 2006-01-10 Masimo Corporation Flex circuit shielded optical sensor
US6915147B2 (en) * 2001-09-07 2005-07-05 Medtronic Minimed, Inc. Sensing apparatus and process
US7018336B2 (en) * 2001-12-27 2006-03-28 Medtronic Minimed, Inc. Implantable sensor flush sleeve
US7022072B2 (en) * 2001-12-27 2006-04-04 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US20080125751A1 (en) * 2002-01-14 2008-05-29 Edwards Lifesciences Corporation Temperature compensation for enzyme electrodes
US6908535B2 (en) * 2002-03-06 2005-06-21 Medtronic, Inc. Current-to-voltage-converter for a biosensor
US6922330B2 (en) * 2002-04-18 2005-07-26 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor fabricated with laser welded anode sheets
US20040137633A1 (en) * 2002-07-26 2004-07-15 Instrumentation Laboratory Company Aqueous solutions for reducing the rate of oxygen loss, and methods thereof
US20040058453A1 (en) * 2002-09-20 2004-03-25 3M Innovative Properties Company Reaction pouch comprising an analytical sensor
US6991096B2 (en) * 2002-09-27 2006-01-31 Medtronic Minimed, Inc. Packaging system
US7241266B2 (en) * 2004-05-20 2007-07-10 Digital Angel Corporation Transducer for embedded bio-sensor using body energy as a power source
US20080033273A1 (en) * 2004-05-20 2008-02-07 Peter Zhou Embedded Bio-Sensor System
US20080033264A1 (en) * 2004-11-23 2008-02-07 Torsten Lonneker-Lammers Pulsoximetry Measuring Device
US20080029390A1 (en) * 2006-02-27 2008-02-07 Joelle Roche Hydrogel for an intravenous amperometric biosensor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200096470A1 (en) * 2017-03-22 2020-03-26 Aalto University Foundation Sr Electrochemical assay for the detection of opioids

Also Published As

Publication number Publication date
US20130075278A1 (en) 2013-03-28
CN101925811A (en) 2010-12-22
US8834703B2 (en) 2014-09-16
EP2223094A1 (en) 2010-09-01
EP2223094B1 (en) 2012-02-15
WO2009073450A1 (en) 2009-06-11
CN101925811B (en) 2013-09-25
EP2434277A1 (en) 2012-03-28
ATE545861T1 (en) 2012-03-15
CA2706592A1 (en) 2009-06-11
CN103529094A (en) 2014-01-22
KR20100103534A (en) 2010-09-27
US20140353153A1 (en) 2014-12-04
EP2434277B1 (en) 2016-10-26

Similar Documents

Publication Publication Date Title
US8141409B2 (en) Sensor calibration
CN108697385B (en) Medical device for detecting at least one analyte in a body fluid
US12048538B2 (en) Detecting an analyte in a body fluid
ES2279805T3 (en) MEDICAL DIAGNOSIS SYSTEM.
DK2422693T3 (en) Device and method for performing at least one medical function
US8834703B2 (en) Preparation and maintenance of sensors
JP2021507764A (en) Medical system and its manufacturing method
US20100000861A1 (en) Packaging system for testing devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HIGGINS, MICHAEL J.;KONNO, MARK;FJIELD, TODD;REEL/FRAME:022523/0891;SIGNING DATES FROM 20090327 TO 20090403

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION